AFFF Firefighting Foam Lawsuit: 2026 Updates and Settlement Predictions

Nguyen Injury Lawyer is actively pursuing AFFF firefighting foam lawsuits nationwide. This page offers the latest updates on the AFFF firefighting foam class action and provides our insights into potential settlement amounts for plaintiffs in AFFF cancer lawsuits. Stay informed with the most current news on AFFF litigation right here.

Our attorneys at Nguyen Injury Lawyer anticipate that the defendants will settle the majority of these lawsuits in 2026, before any trials commence. This prediction is based on the defendants’ past behavior in water contamination lawsuits, where they opted for settlements totaling billions of dollars, seemingly to avoid the unpredictable outcomes of jury trials. Given the strength of the AFFF lawsuits, we believe a similar strategy is likely in the firefighting foam cases to mitigate the risk of substantial jury awards. As we approach individual firefighting foam case trials, our legal team believes this pressure will lead to an AFFF settlement in early 2026. This page will also offer our most up-to-date estimates on potential settlement payouts for AFFF claimants.

AFFF Firefighting Foam Lawsuit at a Glance in January 2026

Current Status

  • Settlement rumors are growing, leading to a significant increase in case filings.
  • New lawsuits are heavily focused on occupational exposure, particularly among firefighters and military personnel.
  • A key motion is pending to consolidate bellwether trials for five Pennsylvania plaintiffs with kidney and/or testicular cancer.
  • The initial bellwether trial will concentrate specifically on kidney cancer claims.
  • The tentative trial date of October 20, 2025, has been rescheduled.

Key Milestones

  • January 29, 2026: Nguyen Injury Lawyer is evaluating new cases.
  • September 16, 2025: Focus on ulcerative colitis trials.
  • September 15, 2025: Nguyen Injury Lawyer is now prioritizing kidney and testicular cancer lawsuits.
  • August 19, 2025: October trial date postponed.
  • July 28, 2025: Progress in Group B Cases.
  • July 18, 2025: Dispute arises over unfiled AFFF lawsuits.
  • July 16, 2025: Recent case count reveals a substantial increase in filed AFFF cancer lawsuits.
  • August 22, 2025 (upcoming): Deadline for defendants’ expert reports.
  • October 20, 2025 (upcoming): Scheduled date for the first bellwether trial (Tier 2 Group A case).

Disease Focus

Six primary conditions are being prioritized due to the strongest evidence of causation:

  • Ulcerative Colitis
  • Liver Cancer
  • Kidney Cancer
  • Testicular Cancer
  • Thyroid Disease (including hypothyroidism)
  • Thyroid Cancer

Estimated Settlement Ranges

  • Tier 1 Cases: $200,000 – $600,000 (e.g., long-term occupational exposure and kidney or testicular cancer)
  • Tier 2 Cases: $150,000 – $200,000
  • Tier 3 Cases: Less than $75,000

⚖️ Legal Insights

  • Bellwether trials will be crucial, but our lawyers predict the lawsuits will settle before reaching that stage.
  • There is a strong emphasis on causation. Science Days and expert challenges will influence the admissibility of critical testimony (Daubert motions).
  • Consolidated trials may provide plaintiffs with strategic advantages by strengthening shared exposure narratives.
  • Discovery and pre-trial phases are intensifying, particularly in ulcerative colitis and cancer subcategories.

⏱️ Urgency to File

Statutes of limitations and a potential global AFFF/PFAS settlement could soon restrict new claims.

Many law firms are encouraging potential claimants to file immediately before a cutoff is implemented.

Supporting Science

  • The National Cancer Institute and the Journal of the National Cancer Institute have linked PFAS to kidney and testicular cancers.
  • Recent studies highlight the dermal and neuronal effects of PFAS exposure.
  • In summary, the scientific evidence continues to strengthen for plaintiffs in 2026.

Latest AFFF Class Action Lawsuit Update (2026)

No More New Cases

January 29, 2026

The desire for settlement is widespread, yet achieving it is proving challenging. AFFF and PFAS lawsuits are inherently more complex to settle than many other mass torts because they extend beyond personal injury. They involve long-term environmental contamination, governmental defendants, and substantial cleanup obligations that go beyond individual plaintiffs.

AFFF firefighting foam cases often involve firefighters and military personnel with cancer claims, while PFAS lawsuits include municipalities, water authorities, and states seeking billions for remediation of contaminated drinking water. This combination of personal injury, public health, and environmental liability makes settlement far more complex than simply compensating injured individuals.

We remain optimistic that a resolution will occur this year, especially for testicular and kidney cancer cases, but it will require some time.

No More New Cases

January 29, 2026

Nguyen Injury Lawyer is pausing the intake of new cases to assess the direction of settlement discussions.

Almost 20,000 Total Cases in MDL

January 6, 2026

As of January 2026, the AFFF firefighting foam MDL includes 15,213 pending cases, with a total of 19,788 cases filed.

Surge of New Cases in MDL

December 9, 2025

With trials approaching, the AFFF class action MDL saw 85 new cases added in November, bringing the total to 15,334 pending cases.

Surge of New Cases in MDL

November 4, 2025

In October, 1,307 new cases were added to the firefighting foam MDL, marking one of the most significant increases in AFFF cases in recent times. The MDL now has 15,249 total pending cases.

New Order

October 2, 2025

The MDL judge has updated the schedule for expert witnesses in thyroid and liver cancer cases. Plaintiffs have already submitted their expert reports, and the defendants have until October 24, 2025, to submit theirs. Plaintiffs’ rebuttal reports are due by November 21, 2025.

The judge emphasized that standard limits on expert discovery apply, generally protecting draft reports and private communications with experts. Lead lawyers from both sides must meet by December 12, 2025, to establish a timeline for expert depositions and arguments regarding the admissibility of expert testimony. A joint schedule is due by December 19, 2025, or each side will submit its own proposal.

Ulcerative Colitis Cases Move Forward

September 16, 2025

The MDL judge has approved the selection of three additional plaintiffs with ulcerative colitis allegations to advance to Tier 2 discovery as part of the Group B bellwether process. These cases, drawn from prior filings, were jointly proposed by plaintiff and defense leadership.

The selected plaintiffs will proceed to Tier 2 discovery, after which one will be chosen, either by agreement or by the judge, to advance to expert discovery. Another plaintiff, previously selected, will also proceed to expert discovery at that time.

The Order allows defendants to remove one of the remaining plaintiffs from the process if plaintiffs’ counsel voluntarily withdraws any of the four current ulcerative colitis bellwether cases, unless good cause is shown (e.g., serious medical hardship).

New Focus

September 15, 2025

We are prioritizing testicular and kidney cancer lawsuits moving forward.

Case Volume Explodes

September 2, 2025

It was known that there were thousands of unfiled AFFF claims. However, the sheer number was unexpected.

Last week alone, 37,446 new claims were filed, triggered by the looming deadline under Judge Gergel’s CMO 35.

PFAS Registry

September 1, 2025

Most of our AFFF and PFAS plaintiffs are veterans or military families. Decades of routine foam use contaminated hundreds of bases, yet there is still no national registry to track exposures and health outcomes. Sick service members are often trapped in red tape, forced to repeatedly prove that their cancers and thyroid disease are linked to time spent on contaminated bases.

The EPA’s new near-zero limits for PFAS in drinking water highlight the dangers of these chemicals. However, without a PFAS registry, veterans are left with promises instead of coordinated medical monitoring and fast diagnoses. This failure makes the AFFF lawsuits even more critical. Litigation is the only way to force accountability when Congress and the VA stall. Veterans did not volunteer for toxic exposure and should not have to fight another battle for recognition and justice.

Trial Date Pushed Back

August 17 2025

The first bellwether personal injury trial in the PFAS foam multidistrict litigation has been postponed due to a substantial backlog of unfiled cases. Judge Richard Gergel created a 21-day “Filing Facilitation Window” in Case Management Order No. 35, running through September 5, 2025.

During this period, the Plaintiffs’ Executive Committee must file all personal injury cases involving the six core conditions identified for this litigation: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer, and thyroid cancer. Other plaintiffs’ counsel are strongly urged to do the same. To simplify the process, the court is temporarily allowing consolidated complaints of up to 150 plaintiffs and the use of short-form pleadings.

Every filing must be supported by evidence submitted through the centralized EAG portal, including proof of diagnosis, drinking water exposure, and residence history. Judge Gergel warned that the sudden surge of unfiled claims threatened to disrupt the orderly management of the MDL and undermine ongoing settlement negotiations. Plaintiffs’ and defense leadership must provide progress reports at 30 and 60 days, and the court signaled that additional case management orders, including early dispositive motions, could follow if compliance lags.

This September 5 date may serve as a de facto cutoff to file a claim in this litigation and qualify for the settlement. If you have a case, act now. Potential plaintiffs cannot wait until the last minute because lawyers need time to gather the necessary documentation and file within the court’s requirements. This is a critical moment for victims of PFAS exposure who want to preserve their ability to seek justice and compensation.

New Study

August 15, 2025

A new study published in Environmental Research analyzed blood from over 300 U.S. firefighters and found clear links between PFAS exposure and changes in microRNAs, molecules that help regulate gene activity. The focus was on PFAS chemicals commonly found in firefighting foam—especially linear and branched forms of PFOS—and their connection to shifts in microRNA expression. One of the strongest findings was that exposure to these chemicals was tied to lower levels of several microRNAs, including miR-128-1-5p and members of the let-7 family. These microRNAs are known for their roles in suppressing tumors and regulating immune responses, raising concerns about the long-term effects of PFAS exposure.

The researchers mapped these microRNA shifts to known disease pathways and found that PFAS were associated with gene expression patterns linked to various illnesses: multiple cancers, including leukemia, kidney, bladder, and liver; neurodegenerative conditions like Alzheimer’s; and autoimmune disorders such as lupus and rheumatoid arthritis. Some PFAS didn’t even have to hit specific microRNAs to light up these pathways, suggesting their damage might be more widespread and insidious than previously understood.

If you or a loved one has been affected by AFFF exposure, contact Nguyen Injury Lawyer at (713) 747-7777 or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

The Genomic Impact of AFFF Exposure

For individuals exposed to AFFF, a recent study serves as a stark warning. It indicates that PFAS chemicals are not merely present in the body but are actively disrupting systems crucial for disease prevention. If we consider toxic exposure as the initial spark, these chemicals represent a slow, insidious burn at the genomic level. This underscores the urgency for affected individuals to seek answers, demand accountability, and obtain the necessary support. Contact Nguyen Injury Lawyer at (713) 747-7777 or visit our website at https://www.nguyeninjurylawyer.com to discuss your legal options.

New AFFF Lawsuit Filed

August 5, 2025: A new lawsuit has been filed by an Arcola, Illinois resident, joining the AFFF MDL. The plaintiff alleges that PFAS exposure from firefighting foam led to the development of kidney cancer. As a former firefighter in both military and civilian roles, the plaintiff experienced regular AFFF exposure during training exercises and emergency responses. Furthermore, the plaintiff consumed and utilized water from contaminated sources while living and working in Wisconsin, a location specifically mentioned in the complaint.

The lawsuit names the corporations involved in the design, manufacture, and distribution of AFFF products, as well as suppliers of fluorosurfactants and chemical precursors used in the foam. The plaintiff asserts that these companies were aware, or should have been aware, of the serious health risks associated with PFAS, including their environmental persistence, accumulation in the human body, and links to cancer and other diseases. If you believe you have been harmed by AFFF exposure, contact Nguyen Injury Lawyer for a consultation at https://www.nguyeninjurylawyer.com/contact.

AFFF Lawsuit Updates: Preparing Group B for Trial

July 28, 2025: Judge Gergel has approved a joint request from both parties, extending the deadline to August 4, 2025, for proposing a selection process for additional discovery pool plaintiffs in the Tier 2 Group B cases, as outlined in Case Management Order 26H. This extension allows both sides additional time to negotiate the next group of cases for in-depth discovery.

Previously, the Court designated three Group B Tier 2 cases—two involving ulcerative colitis plaintiffs and one involving a thyroid disease plaintiff—and instructed the parties to recommend a selection process for additional cases by June 27, 2025. This deadline has now been extended. Discovery for Tier 2 Group B is scheduled to conclude on September 12, 2025, unless a further extension is granted. Nguyen Injury Lawyer is closely monitoring these developments. Call us at (713) 747-7777 for updates.

The Importance of Treating Physicians at Trial

July 24, 2025: In class action and MDL litigation, a significant amount of time is dedicated to establishing general causation, which is essential for proceeding past summary judgment and reaching a jury. However, the dynamics shift when a case moves from paperwork to the courtroom. Trials revolve around human stories presented to jurors who seek trustworthy figures. This is where treating physicians become invaluable.

These witnesses, who observed the plaintiff’s condition firsthand, were not hired for their testimony and generally have no vested interest in the outcome beyond their patient’s well-being. Their authenticity is a powerful asset. A treating physician enters the courtroom without the perceived bias of a hired expert, influencing how jurors perceive their testimony. When a treating doctor explains observed symptoms, conducted tests, and the progression of the illness in clear clinical terms, it grounds the plaintiff’s suffering in reality. It transforms the experience from an abstract concept to a tangible reality, supported by medical records, emergency room visits, and daily struggles that the jury can visualize. A skilled trial lawyer understands the importance of allowing causation experts to pave the way, but then allowing the treating physician and other witnesses to illustrate the human impact. Contact Nguyen Injury Lawyer at https://www.nguyeninjurylawyer.com for experienced legal representation.

Firefighter PFAS Injury Compensation Act

July 23, 2025: The Firefighter PFAS Injury Compensation Act of 2024, a bipartisan bill introduced by Senator Cory Booker, aims to provide direct compensation and medical benefits to firefighters exposed to toxic PFAS chemicals, particularly through aqueous film-forming foam (AFFF). These chemicals have been strongly linked to various serious illnesses, many of which are central to the ongoing AFFF litigation.

The bill establishes a federal compensation program covering two categories of PFAS-related health conditions:

  • Tier 1 / Category A Injuries: Kidney cancer, testicular cancer, liver cancer, thyroid cancer, qualifying thyroid diseases, and ulcerative colitis.
  • Category B Injuries: Prostate cancer, breast cancer, pancreatic cancer, and bladder cancer.

This bill creates a separate and independent avenue for recovery, unrelated to the outcomes of the current PFAS/AFFF lawsuits. It represents a legislative effort to acknowledge and address the harm firefighters have suffered due to occupational exposure to PFAS chemicals, offering an additional layer of justice and compensation outside the court system. The attorneys at Nguyen Injury Lawyer are following this legislation closely.

The passage of any legislation requiring new federal spending faces significant challenges in the current political environment. Budgetary constraints and partisan divisions make it difficult for even widely supported bills to advance quickly. However, we remain hopeful that Congress will recognize the severity of the harm and take appropriate action. Contact Nguyen Injury Lawyer at (713) 747-7777 to discuss your rights and potential compensation.

Unfiled Claims and AFFF Litigation

July 22, 2025: Judge Richard Gergel has scheduled an emergency teleconference today to address a surge in unfiled personal injury claims. The reported sudden increase of tens of thousands of potential claims raises concerns about possible disruptions to ongoing global settlement talks ahead of the first bellwether trial, scheduled for October.

The defense’s actions suggest that the defendants’ negligence resulted in a greater number of cancer cases than initially anticipated. A trial is scheduled for October, and the defendants can either settle the lawsuits or proceed to trial. A conference with the judge will not alter these fundamental choices.

Judge Gergel has directed plaintiffs’ AFFF attorneys to provide detailed counts of both filed and unfiled claims, identifying firms with over 100 unfiled cases. The defense argued that this influx poses a threat to case management and undermines the bellwether process, prompting their request for court intervention. While plaintiffs accused the defense of breaching mediation confidentiality, Gergel sided with the defense, asserting the court’s right to be informed. Nguyen Injury Lawyer is committed to protecting your rights throughout this process. Contact us today for a free consultation.

AFFF Settlement on the Horizon?

July 21, 2025: A group of firefighters from across the country has filed a lawsuit in Madison County, Illinois, alleging they suffered serious health consequences from long-term exposure to toxic chemicals in firefighting foam and protective gear.

The plaintiffs, both current and former civilian and military firefighters, claim that products manufactured and distributed by over 50 companies contained PFAS. The complaint alleges that companies such as 3M, DuPont, Chemours, and others were aware for decades of the health risks associated with PFAS exposure, including an increased risk of cancer and other chronic conditions. Despite this knowledge, they allegedly failed to warn users or remove their products from the market. The lawsuit further asserts that the defendants continued to manufacture and promote AFFF and turnout gear containing PFAS even after internal studies and regulatory pressure revealed the harmful effects of these chemicals. If you believe you have been affected, reach out to Nguyen Injury Lawyer for guidance. Our number is (713) 747-7777.

Plaintiffs in the case have been diagnosed with a range of conditions, including kidney, thyroid, and testicular cancer, ulcerative colitis, and thyroid disease. They claim they used the products as intended and were never informed of the risks, nor were they provided with protective measures to guard against PFAS exposure.

The defendants intend to transfer this case to the AFFF MDL, and we will be monitoring the proceedings closely.

Tensions Rise in AFFF MDL Over Mediation Data and Unfiled Claims

July 18, 2025: A dispute has emerged in the Aqueous Film-Forming Foam MDL after defense lawyers requested a court conference to address what they described as an “accelerating” number of unfiled personal injury claims, reportedly now in the tens of thousands. Citing concerns about case management, scheduling, and the bellwether process, the defense urged the court to intervene before the next mediation session scheduled for July 25, 2025.

In response, plaintiffs’ lawyers expressed frustration that the defense attorneys had violated the Mediation Agreement and Federal Rule of Evidence 408, which protects communications made during settlement discussions. According to the plaintiffs, the unfiled case data referenced by the defense was gathered solely for mediation purposes at the defense’s own request, with the understanding that it would remain privileged and not be used for litigation advantage.

Plaintiffs expressed frustration that the defense acted unilaterally, bypassing the mediators and giving minimal notice to opposing counsel. They emphasized that this move undermines nearly three years of good-faith negotiations under Judge Phillips’ supervision and warned that if the defense intends to bring mediation material into court, plaintiffs are prepared to respond in kind.

The number of unfiled lawsuits has been a known issue in this litigation, and should not come as a surprise to anyone.

MDL Judge Pushes for AFFF Settlement

July 1, 2025: At the last status conference, Judge Gergel urged the parties in the AFFF multidistrict litigation to settle personal injury claims before the first bellwether trial, set for October. Stressing the urgency, he told 3M, DuPont, BASF, Johnson Controls, and other defendants to settle those lawsuits sooner rather than later. The trial will focus on kidney cancer claims, with thyroid and other illnesses to follow. More than 10,000 cases are pending, including claims for personal injury, environmental contamination, and property damage linked to PFAS in firefighting foam.

If you have not yet filed an AFFF lawsuit, now is the time to act. A comprehensive settlement in this litigation is highly likely this summer. Prior settlements with public water systems have already surpassed $13 billion, and the pressure is mounting on defendants to resolve personal injury claims before bellwether trials begin this fall. The presiding judge has signaled growing impatience, and the financial risks of taking these cases to trial are driving serious settlement discussions that our attorneys at Nguyen Injury Lawyer believe will yield favorable outcomes. Visit https://www.nguyeninjurylawyer.com to learn more.

Path to Trial in AFFF Litigation

June 17, 2025: Judge Gergel has issued a scheduling order that establishes the framework for the first personal injury bellwether trial, or at least one of three potential cases involving kidney cancer claims linked to AFFF exposure.

While the court has not yet determined which of the three plaintiffs—Donnelly, Speers, or Voelker—will proceed first, this order sets deadlines that will apply to whichever case is ultimately selected. This structure indicates that the major MDL is shifting from pretrial chaos to the reality of an actual trial. We are now witnessing the preparations for an October 2025 trial, signaling that parties are becoming serious about exhibit lists, witness preparation, and jury strategy.

The order outlines a detailed timetable for all aspects of the trial, from voir dire proposals to deposition designations and objections to exhibits. Both sides are required to coordinate on juror questionnaires, exchange deposition transcripts in Excel format, and provide up to 500 “core exhibits” likely to be used at trial. This indicates the judge’s desire for a well-organized and efficient MDL. There are even rules governing the disclosure of last-minute demonstratives and summary exhibits, ensuring both parties have a fair opportunity to present their case before a jury. For plaintiff’s attorneys preparing for trial, now is the time to finalize evidence and carefully consider how to present a clear and compelling narrative. Nguyen Injury Lawyer is dedicated to helping you navigate this complex litigation. Call us at (713) 747-7777 for a free consultation.

Trial Date Looms in AFFF Lawsuits

The trial is currently scheduled to commence with jury selection on October 20, 2025. Leading up to that date, we anticipate a flurry of pretrial briefs, exhibit conferences, and witness disclosures. Judge Gergel has mandated that pretrial briefs be submitted by October 3, with a readiness conference set for October 16, signaling an end to delays. Plaintiffs awaiting their day in court are finally witnessing progress toward actual trial dates. The science, corporate knowledge, and warnings (or lack thereof) are poised to be scrutinized before a jury, unless a global AFFF settlement materializes, which is our expectation.

New Firefighter Study

June 3, 2025

A new peer-reviewed study, “Differences in serum concentrations of per-and polyfluoroalkyl substances by occupation among firefighters, other first responders, healthcare workers, and other essential workers in Arizona, 2020–2023,” provides significant scientific validation to the growing body of evidence in the Aqueous Film-Forming Foam (AFFF) lawsuits.

This study, conducted on nearly 2,000 frontline workers in Arizona, analyzed blood serum samples from 2020 to 2023, measuring 14 PFAS chemicals and tracking exposure differences across various job types.

The findings reveal that firefighters exhibited notably higher levels of critical PFAS chemicals, including PFHxS, PFOS, and PFHpS, compared to other essential workers, even after accounting for factors such as age, sex, ethnicity, year, and location. These substances are directly associated with AFFF, commonly used in firefighting operations. Additionally, healthcare workers showed elevated odds of detecting other PFAS compounds (Sb-PFOA, PFDoA), highlighting broader concerns regarding occupational exposure.

This study offers direct, recent, and well-controlled evidence that AFFF occupational use correlates with increased PFAS levels in firefighters, bolstering causation arguments in personal injury claims. It demonstrates that even within a group of frontline workers, firefighters face unique and disproportionate exposure. These findings make it increasingly challenging for chemical manufacturers and distributors to refute the connection between AFFF and the accumulation of toxic PFAS in the human body.

The conclusion is clear: PFAS contamination from AFFF is not merely speculative. It is measurable, linked to occupation, and supported by robust epidemiological data. This study supports the plaintiffs’ central argument that PFAS exposure through AFFF is a known hazard with foreseeable consequences, and manufacturers must be held accountable. Contact Nguyen Injury Lawyer at (713) 747-7777 to discuss your case.

Ulcerative Colitis Bellwether Plaintiffs Added

April 26, 2025

The MDL judge issued Case Management Order 26H to update the schedule for the Group B personal injury bellwether cases involving ulcerative colitis claims.

Three new plaintiffs alleging ulcerative colitis were added to the discovery pool, and Tier 1 discovery for these plaintiffs will run from April 7, 2025, to August 11, 2025. By July 21, 2025, the parties must propose a process for selecting which of these new plaintiffs should move into Tier 2, with the expectation that at least one will be chosen, although the judge can decide to move more than one forward.

For all Group B plaintiffs already in Tier 2, discovery started back in July 2024 and is still scheduled to close by September 12, 2025, unless extended. The parties will update the MDL judge at an August 8, 2025, status conference about how discovery is progressing and whether additional time will be needed. After discovery concludes, the parties will proceed to expert discovery, based on a schedule they are still finalizing.

This order underscores that ulcerative colitis cases are picking up momentum and are being positioned for possible bellwether trials and potential settlement leverage. By setting a clear structure, the MDL judge is signaling that these cases need to be trial-ready soon, likely by late 2025 or early 2026. The judge’s direction to select at least one new ulcerative colitis plaintiff for Tier 2, along with early preparations for expert discovery, arguably suggests an intent to maintain pressure on both sides and move the cases closer to resolution, whether through trial or settlement. Contact Nguyen Injury Lawyer at (713) 747-7777 to discuss your case.

Fear of Punitive Damages May Drive AFFF Settlement Amounts

January 28, 2025

Punitive damages will be a key driving force in increasing AFFF lawsuit settlement amounts and will likely be key to forcing the defendants to settle before the first personal injury trial this year.

Punitive damages are intended to penalize defendants for egregious misconduct and discourage similar behavior in the future. In AFFF litigation, plaintiffs assert that manufacturers like 3M and DuPont not only neglected to warn the public about the dangers of AFFF foam but also actively concealed evidence of its toxicity for decades. This deliberate and reckless conduct aligns precisely with the purpose of punitive damages. Jurors may be inclined to hold companies accountable for prioritizing profits over people, potentially leading to substantial awards exceeding compensatory damages, which would create significant financial exposure for defendants.

The firefighting foam lawsuits are set up for punitive damages. Internal documents reveal that companies were aware of the risks associated with PFAS chemicals as early as the 1960s, yet they failed to warn workers, firefighters, and communities. This high-stakes environment often prompts defendants to pursue settlement to avoid unpredictable and substantial jury verdicts. Plaintiffs involved in these lawsuits—whether for personal injury, property damage, or environmental harm—stand to benefit significantly as settlement negotiations aim to reflect not only their individual damages but also the severity of the manufacturers’ misconduct. Contact Nguyen Injury Lawyer through our contact page to discuss your case.

New Navy Firefighting Foam Lawsuit

October 23, 2024

In a new lawsuit filed yesterday, a plaintiff from Boerne, Texas, is seeking damages in the MDL, alleging injury from exposure to PFAS-containing firefighting foam (AFFF) products manufactured by multiple companies, including 3M, Chemours, and DuPont. The plaintiff claims that repeated exposure to AFFF during a U.S. Navy career led to a diagnosis of thyroid cancer and other serious health issues due to the deadly bioaccumulative and carcinogenic properties of PFAS compounds within the foam.

New Study Provides New Tool For AFFF Lawsuits

June 27, 2024

A new study enhances our understanding of how PFAS interact with human skin. Researchers utilized in vitro 3D human skin equivalent models to analyze the absorption of 17 different PFAS when applied to the skin. They discovered that shorter-chain PFAS exhibited higher absorption rates and that absorption decreased with increasing carbon chain length of the compounds.

Notably, while longer-chain PFAS were not directly absorbed into the skin, a significant portion of these chemicals was retained within the skin tissue, potentially releasing into the body over time. The study also underscored the influence of physicochemical properties on the dermal permeation of PFAS, revealing a clear inverse correlation between the lipophilicity of the substances and their absorption through the skin.

This study provides a powerful new tool for plaintiffs’ experts in AFFF firefighting foam lawsuits. The detailed analysis of PFAS absorption through the skin confirms that dermal exposure to these chemicals can significantly contribute to the body burden of PFAS.

This is particularly relevant in cases where plaintiffs have been exposed to firefighting foams containing PFAS. It provides a scientifically supported pathway of exposure that can directly link PFAS-containing products to the health problems these firefighters are experiencing. This evidence reinforces claims that manufacturers like 3M should have recognized and cautioned against the risks associated with dermal exposure to PFAS. Contact Nguyen Injury Lawyer at (713) 747-7777 to discuss your case.

Court Focuses More On Turnout Gear Claims

March 6, 2024

We have not discussed the turnout gear PFAS claims extensively. As the court increasingly focuses on these claims, let’s examine them more closely.

The case against the manufacturers of turnout gear involves allegations that exposure to per- and polyfluoroalkyl substances (PFAS), chemicals used in the protective clothing worn by firefighters, has resulted in various health issues, including cancer and other illnesses.

Firefighter turnout gear, also known as protective gear, is designed to shield firefighters from heat, flames, and chemical exposure during firefighting operations. Plaintiffs contend that the turnout gear, which contains PFAS, has exposed them to harmful chemicals, leading to adverse health effects such as cancer, liver damage, thyroid disease, and other injuries.

A new court order, Case Management Order No. 5F, establishes procedures for the creation, submission, and management of Plaintiff Fact Sheets specific to cases involving claims related to firefighter turnout gear.

The order mandates the creation of a specific Plaintiff Fact Sheet (PFS) tailored for cases involving claims against manufacturers of firefighter turnout gear. This is a new requirement for plaintiffs who are making these claims to fill out this fact sheet. Visit Nguyen Injury Lawyer for more information.

New Study Provides Strong Link Between AFFF And Testicular Cancer

October 5, 2023

This study provides the strongest evidence to date of the link between testicular cancer and AFFF. While substantial evidence already existed, this study further solidifies the connection.

Recent Study Links AFFF To Testicular Cancer

August 20, 2023

A recent study confirms what Nguyen Injury Lawyer has long understood from calls with victims: AFFF may increase the risk of testicular cancer.

Former Air Force Firefighter Joins AFFF MDL

August 18, 2023

A new AFFF lawsuit, Jones v. 3M, et al., was directly filed last week in the AFFF MDL in South Carolina against the usual defendants.

The plaintiff, a 73-year-old Texas man, was exposed to fluorochemical products during his service as a firefighter with the Air Force. He alleges that he was diagnosed with prostate cancer from AFFF exposure, which has caused him to undergo a prostatectomy. His lawsuit seeks compensation for his pain, suffering, and other damages.

Most of our military AFFF lawsuits are from the Navy, but we also see cases from the Army and Air Force. Contact Nguyen Injury Lawyer at (713) 747-7777 to discuss your case.

Judge Grants Unopposed Motion To Substitute Plaintiff

August 1, 2023

Judge Gergel granted an unopposed motion to substitute plaintiffs after an Alabama plaintiff passed away. The man’s daughter is now the plaintiff in a wrongful death lawsuit. It is a stark reminder that many plaintiffs in this litigation may not live to see their settlements.

Three Leading Companies To Create Billion-Dollar Settlement Fund

June 2, 2023

Three leading companies—The Chemours Company, DuPont de Nemours, and Corteva—have reached a preliminary agreement to address PFAS-related drinking water claims involving public water systems. Together, they will establish a $1.185 billion settlement fund, which will be divided according to their agreed-upon contributions. The settlement awaits final approval from the United States District Court for the District of South Carolina. The deal excludes specific water systems.

Statute Of Limitations

February 3, 2023

Many individuals exposed to firefighting foam delay contacting Nguyen Injury Lawyer because they believe the statute of limitations prevents them from filing a claim. While most states have statutes of limitations of two to three years for personal injury lawsuits, this short deadline leads many victims to believe they have run out of time.

Understanding the Statute of Limitations in AFFF Lawsuits

The reality surrounding statutes of limitations can be complex. Most states adhere to a discovery rule that may extend the filing deadline in toxic exposure cases, including AFFF lawsuits. According to this rule, the statute of limitations does not begin until the plaintiff knows, or reasonably should have known, about their injury and its connection to AFFF exposure. For many, this realization occurs years after the initial exposure, often upon receiving a cancer diagnosis or when the link between PFAS in firefighting foam and their condition becomes widely recognized.

This is why numerous AFFF lawsuits have been filed within the federal MDL, even when the alleged exposures occurred decades ago. Courts have consistently allowed these claims to proceed based on the discovery rule. Furthermore, some states have specific statutes addressing toxic torts, fraud, or concealment, which can further extend the filing deadline if defendants withheld crucial safety information from the public.

Ultimately, individuals exposed to AFFF should not assume their filing window has closed. The statute of limitations and the discovery rule are intricate, with state-specific exceptions. Many who initially believed they had no claim in 2024 or 2025 have since discovered their cases are viable. If you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, or another condition linked to PFAS in firefighting foam, Nguyen Injury Lawyer recommends seeking a legal review of your case before assuming you have no options. Contact us at (713) 747-7777 or through our website at https://www.nguyeninjurylawyer.com.

Recent Developments in AFFF Litigation

Occupational Medicine Reports Firefighters 60% More Likely To Die Of Cancer

January 12, 2023

A new study published in the journal Occupational Medicine indicates that firefighters face a 60% higher risk of cancer-related death compared to the general population. The study revealed significantly elevated death rates for specific cancers: prostate cancer was four times higher, leukemia three times higher, and kidney cancer twice as high as in the general population. Researchers suggest that carcinogenic chemicals present in AFFF may be a primary contributing factor.

Retired Judge Layn Phillips Appointed Settlement Mediator

November 1, 2022

With the initial bellwether trial scheduled for 2024, a court-appointed settlement mediator, retired Judge Layn Phillips, has been assigned to “facilitate and encourage” global settlement discussions between the involved parties. Judge Phillips faces a challenging task, considering the AFFF litigation encompasses cancer claims from individual firefighters and claims from local municipalities concerning water supply contamination.

Reaching an AFFF settlement will be a complex undertaking due to the diverse nature of the claims, involving both individuals and entire communities. Furthermore, the various defendants may hold differing perspectives on what constitutes a fair AFFF settlement. However, there remains the possibility of achieving some AFFF settlements through this mediation, which would benefit all parties involved. The water contamination cases are likely to be addressed first, given their earlier trial date.

Firefighting Foam (AFFF) Class Action Lawsuit

Aqueous film-forming foam (“AFFF”), commonly known as firefighting foam, is used to extinguish fires. Recent discoveries have revealed that prolonged use or exposure to certain chemicals in AFFF firefighting foam can cause cancer. Individuals regularly exposed to firefighting foam and subsequently diagnosed with kidney, pancreatic, prostate, or testicular cancer may be eligible to file an AFFF firefighting foam lawsuit and receive financial compensation.

All AFFF firefighting foam lawsuits in federal courts have been consolidated into a “class action” MDL in the District of South Carolina. As of August 2022, over 2,500 plaintiffs with firefighting foam cancer lawsuits are pending in the AFFF MDL. Following bellwether test trials, the AFFF class action MDL is expected to conclude with a global settlement.

AFFF Firefighting Foam Causes Cancer

AFFF (“aqueous film-forming foam”) is a sprayable foam specifically designed to extinguish high-intensity fires fueled by accelerants such as gasoline. The active chemicals in AFFF firefighting foam belong to a family of chemicals known as PFAS (poly-fluoroalkyl substances).

PFAS are a unique group of chemicals highly resistant to extreme heat and unaffected by oil or water. Unfortunately, their indestructible nature means they do not biodegrade or break down in the environment. These substances are characterized by extraordinarily robust and enduring carbon-fluorine bonds. PFAS are often referred to as “forever chemicals” due to their remarkable persistence in the environment and strong resistance to metabolic and environmental degradation.

Over the last decade, emerging scientific research has established that chronic exposure to PFAS in firefighting foam can cause certain types of cancer. The Environmental Protection Agency published a health advisory in 2016 noting that animal studies showed that prolonged exposure to PFAS resulted in kidney and testicular cancer.

The International Agency for Research on Cancer (IARC) has conducted several studies that found that human exposure to PFAS results in a significantly increased rate of kidney, prostate, and testicular cancer.

The Centers for Disease Control and Prevention (CDC) and the American Cancer Society have reached the same conclusion, listing the chemicals in AFFF firefighting foam as human carcinogens.

Exposure to AFFF Firefighting Foam and PFAS

Individuals regularly exposed to AFFF firefighting foam over extended periods are potentially at risk of developing cancer from PFAS. Chronic exposure to PFAS in AFFF firefighting foam can occur through occupational exposure to AFFF and PFAS contamination in drinking water.

Occupational AFFF Exposure

Individuals who worked in specific jobs or professions where AFFF firefighting foam was regularly used (either directly or by those around them) are considered to have “occupational exposure” to PFAS from firefighting foam.

If you believe you have a claim, contact Nguyen Injury Lawyer today at (713) 747-7777 or visit our contact page at https://www.nguyeninjurylawyer.com/contact.

Who Is at Risk from AFFF Exposure?

Firefighters who routinely used AFFF or participated in training exercises involving AFFF are among the most prominent individuals with occupational exposure. They comprise a significant portion of the plaintiffs in the AFFF class action lawsuit.

Since the late 1960s or early 1970s, the U.S. military has utilized MilSpec AFFF at military installations, airfields, and naval vessels. These locations face a higher risk of fuel fires, which can be catastrophic. The military employs this substance for training, fire suppression, and the protection of lives and property. However, personnel using these products were often unaware of their exposure to per- and polyfluoroalkyl substances (PFAS) present in AFFF.

Beyond the military, other individuals who may have experienced occupational exposure to AFFF include those working in environments where AFFF was heavily used, disposed of, or manufactured. Commercial airports, where fuel fires pose a significant risk, frequently use firefighting foam during safety drills and emergency response training. Similarly, industrial facilities, particularly those dealing with flammable materials, also regularly incorporate AFFF into their fire safety protocols.

Nguyen Injury Lawyer is currently handling numerous:

  • Navy AFFF lawsuits
  • Groundwater PFAS Exposure

Another group facing chronic PFAS exposure from AFFF includes individuals who consumed drinking water contaminated with PFAS. Numerous residential areas nationwide have experienced groundwater contamination due to PFAS from firefighting foam.

Many residential areas with PFAS-contaminated groundwater are located near military bases or airports where AFFF was routinely used. The PFAS in the firefighting foam eventually seeped through the soil and into the water table.

AFFF Class Action Lawsuit: Number of Plaintiffs

As of July 2025, the AFFF (firefighting foam) class action MDL-2873 includes nearly 11,000 pending lawsuits.

These lawsuits encompass both municipal water contamination cases and individual personal injury claims. Many of the latter are filed by former firefighters alleging they developed cancer due to AFFF exposure. While the exact number of cases in each category is not specifically tracked, personal injury and wrongful death claims related to firefighting foam exposure constitute the majority of current lawsuits.

Who Are the Defendants in AFFF Lawsuits?

The defendants in the AFFF lawsuits are companies that manufactured and sold AFFF products. Various companies have been involved in the production and sale of firefighting foam. DuPont and 3M, as two of the largest manufacturers of AFFF, are key defendants in the current AFFF litigation.

Evidence suggests that by the 1970s, manufacturers like 3M, DuPont, and others were aware of the potential environmental toxicity of PFAS in their AFFF products. Furthermore, by the 1990s, these companies recognized the potential harm of these chemicals to humans and the possible link between long-term exposure and cancer.

AFFF Lawsuit Settlement Amounts

The AFFF lawsuits are expected to be resolved through a mass tort global settlement. In these settlements, the defendants contribute a substantial sum to a settlement fund, which is then used to compensate individual plaintiffs who agree to accept the settlement.

The settlement compensation awarded to individual plaintiffs is determined by a tiered ranking system. Plaintiffs with the strongest AFFF cancer cases are placed in the top tier and receive the highest settlement payouts. Plaintiffs with weaker claims are assigned to lower tiers and receive correspondingly lower compensation.

In the AFFF lawsuits, the top settlement tier will likely include plaintiffs with long-term occupational exposure to AFFF and a diagnosis of one of the more serious cancers linked to AFFF, such as prostate, testicular, or liver cancer, thyroid disease, and ulcerative colitis. AFFF plaintiffs in lower settlement tiers may have experienced less occupational exposure or been diagnosed with less severe forms of cancer. Nguyen Injury Lawyer anticipates that cancer cases will receive the highest settlement values.

Drawing upon settlement payouts in previous mass tort cases involving cancer, our attorneys estimate that AFFF firefighting foam cases in the top settlement tier may yield average settlement amounts ranging from $300,000 to $600,000. We estimate the value for second-tier cases to be between $150,000 and $280,000. In some instances, third-tier cases may result in settlement payouts of $75,000 or less.

It’s crucial to recognize that these figures are projections and not guarantees of future AFFF settlement ranges for individual claims. Nguyen Injury Lawyer strives to provide the most accurate settlement predictions possible. However, any claims of certainty regarding the timing and amounts of AFFF settlements should be viewed with skepticism.

We hope to gain clarity on potential AFFF settlement offers soon. There is speculation about a settlement, at least with some of the defendants, occurring in the first half of 2025. Contact Nguyen Injury Lawyer today at (713) 747-7777 or through our website’s contact page at https://www.nguyeninjurylawyer.com/contact for more information.

FAQs

As of January 2026, the AFFF multidistrict litigation (MDL 2873) has experienced a notable increase in cases, exceeding 15,000 active lawsuits. This surge reflects growing awareness and concern regarding the health impacts of AFFF exposure. Some individuals are only now recognizing the connection between PFAS exposure and their cancer or related diseases, while others are filing lawsuits in anticipation of a potential AFFF settlement. Nguyen Injury Lawyer is closely monitoring these developments.

Several factors influence settlement amounts, including the severity of the plaintiff’s illness, the extent of AFFF exposure, and the strength of the evidence linking the exposure to the illness. Current projections suggest that settlements could range from $200,000 to $1,000,000 or more, depending on the specific circumstances of each case.

The AFFF litigation is increasingly being compared to asbestos lawsuits due to the widespread use of PFAS chemicals and their serious health implications. Experts anticipate that PFAS-related claims may become one of the most extensive and complex areas of toxic tort litigation, similar to asbestos. Nguyen Injury Lawyer is prepared to handle the complexities of these cases.

MDL 2873 centralizes all federal AFFF lawsuits to streamline pretrial proceedings and ensure consistent rulings. This consolidation, under Judge Richard M. Gergel in the District of South Carolina, aims to efficiently manage the growing number of cases and facilitate potential settlements.

Recent epidemiological research continues to strengthen the evidentiary foundation for plaintiffs in AFFF litigation. Studies have reinforced the direct link between PFAS exposure, particularly from aqueous film-forming foam, and increased cancer risks, especially kidney and testicular cancer. These findings have significant implications for both bellwether trial outcomes and the broader settlement landscape. A critical study from the National Cancer Institute demonstrated a statistically significant association between PFAS exposure and testicular cancer among U.S. Air Force servicemen, an occupational group with extensive AFFF exposure. This study is expected to serve as a key piece of scientific evidence as plaintiffs’ counsel advances causation arguments in court. Similarly, a landmark study published in the Journal of the National Cancer Institute has identified a direct correlation between elevated PFAS serum levels and an increased incidence of kidney cancer. This research is expected to bolster general causation arguments, challenging defense claims that PFAS exposure lacks a definitive cancer link. The weight of these studies extends beyond mere expert reports. This is the kind of peer-reviewed, government-backed research that courts take seriously, particularly in Daubert and Frye hearings that determine what evidence is admissible at trial. As the scientific consensus around PFAS toxicity solidifies, Nguyen Injury Lawyer anticipates a shift in defense strategy, with heightened settlement positioning as corporate defendants assess the risks of adverse verdicts in upcoming trials. We believe that taking one of these cases to trial would be unwise for the defendants, and they appear to recognize this. For individuals affected by AFFF-related illnesses, this growing body of research strengthens the case for holding manufacturers accountable. As we approach the resolution of these cases, expect these studies to become pivotal in establishing both general and specific causation, areas where the defense faces increasing challenges. The scientific evidence supporting these cases is compelling.

Individuals who have been exposed to AFFF/PFAS and subsequently diagnosed with related health conditions should consult with experienced attorneys specializing in toxic torts. Nguyen Injury Lawyer can evaluate your case and determine your eligibility for filing a lawsuit. Contact us for a free consultation at (713) 747-7777 or visit our contact page at https://www.nguyeninjurylawyer.com/contact. Exposure to AFFF has been linked to several severe health conditions. The six primary conditions associated with AFFF exposure that Nguyen Injury Lawyer is focusing on are:

As of February 2026, the exact resolution timeline for the AFFF lawsuit remains uncertain. However, Nguyen Injury Lawyer anticipates a resolution soon. We may cease accepting new claims later this month and certainly before September 5, 2025, as previously discussed.

Documents have emerged indicating that manufacturers like 3M were aware of the toxic nature of PFAS chemicals in their firefighting foams but continued production without adequate warnings. This evidence of potential corporate misconduct could significantly impact the litigation, potentially leading to higher settlement amounts or punitive damages if defendants choose to proceed to trial. Nguyen Injury Lawyer is committed to holding these manufacturers accountable.

We’re here to help, 24 hours a day, 7 days a week

833-ChiWins (713) 747-7777